Intravenous Ascorbate Plus Gemcitabine/Carboplatin: A Novel and Cost-Effective Alternative With Evident Efficacy in Patients With Muscle Invasive Bladder Cancer
Clinical trial NCT06493370 · RECRUITING
Trial details
- NCT number
- NCT06493370
- Sponsor
- University of Kansas Medical Center
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-16
- Primary completion
- 2028-12-01
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.